How should a pharmaceutical company prepare for a remote evaluation? Response:

Question

Options

• ABy training staff on remote communication tools and digital documentation practices.
• BBy increasing the security around their physical facilities.
• CBy organizing a public relations campaign.
• DBy revising their product pricing strategy.

• A
  76% (29)
• B
  8% (3)
• C
  13% (5)
• D
  3% (1)

Explanation

Option A is correct because remote evaluations (such as regulatory inspections conducted via video conference or electronic document review) require staff to be proficient with digital communication platforms and able to submit, organize, and present documentation electronically - the entire evaluation happens through these tools. Option B is irrelevant since remote evaluations involve no physical site visit, making facility security a non-factor. Option C (a PR campaign) addresses public perception, not regulatory compliance readiness. Option D (pricing strategy) is a business/commercial concern entirely unrelated to the evaluation process.

Memory tip: Think "remote = digital" - if inspectors never set foot on-site, your preparation must be virtual: your people, your tools, and your documents all need to be ready to work through a screen.

No community discussion yet for this question.